KemPharm Adds Potential Therapy for Idiopathic Hypersomnia to Its Product Pipeline
KemPharm is investigating “KP1077” as a potential treatment for idiopathic hypersomnia (IH), a sleep disorder of excessive sleepiness.
Read MoreKemPharm is investigating “KP1077” as a potential treatment for idiopathic hypersomnia (IH), a sleep disorder of excessive sleepiness.
Read MoreThe team is working on rolling out this clinical tool, called the “Let Sleeping Patients Lie,” in several hospitals across Northwell Health.
Read MoreMade of N99-rated filter material, the patent-pending PortPatch is intended to reduce the spread of airborne particulates.
Read MoreTheir findings are particularly relevant in the context of a pandemic, when adolescents’ mental health is already under strain.
Read MoreThe caucus became official in October when the US House of Representatives Committee on House Administration updated its roster of congressional member organizations.
Read More